TECHNOLOGICAL INNOVATION AT THE SERVICE OF HEALTH
The Cliniporator® is the most advanced medical device to complete the entire process of electroporation of cancerous cells in a few minutes.
Its ease of use allows reduced surgery time in the operating theatre, enabling a large number of lesions to be treated in a single session.
The Cliniporator® induces electroporation of the cell membrane by emitting high voltage impulses which permit the intra-cellular diffusion of molecules that otherwise would not be able to enter the cells.
Specific electrodes are designed for lesions of the skin, mucous membranes and subcutaneous tissue to a depth of 4 centimeters, ensuring that electroporation of the cancerous tissue is homogeneous, and guarantees the effectiveness of the treatment on the entire area of interest.
During the electroporation process, Cliniporator® measures the voltage and current supplied, and displays critical treatment information in real time, allowing the physician to verify electroporation effectiveness.
The touch screen facilitates the Cliniporator® use through a simple and clear graphic interface.
Recent scientific studies validated the safety Cliniporator® in the treatment of locally advanced pancreatic tumors and hepatic metastases with laparotomic access.
The use of a cardiac synchronisation system leads the delivery of the electrical pulses during the absolute refractory period of the heart, allowing the Cliniporator® to perform a safe treatment of visceral tumours within proximity of the heart.
The Cliniporator® is a highly reliable device, built to meet the most rigorous European safety standards.
The Cliniporator® complies with electrical safety standards EN 60601‐1 and with the requirements of the European Directives for Medical Devices 93/42/CEE and its revised version.
The Cliniporator® is marked CE0051 under the control of the Notification Body IMQ.